These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17038153)

  • 1. Appropriate result from an inappropriate ICD shock.
    Davis DR; Gollob MH; Green MS; Lemery R; Tang AS; Birnie DH
    Pacing Clin Electrophysiol; 2006 Oct; 29(10):1183-4. PubMed ID: 17038153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrical injury during "hands on" defibrillation-A potential risk of internal cardioverter defibrillators?
    Stockwell B; Bellis G; Morton G; Chung K; Merton WL; Andrews N; Smith GB
    Resuscitation; 2009 Jul; 80(7):832-4. PubMed ID: 19446388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.
    Berul CI; Van Hare GF; Kertesz NJ; Dubin AM; Cecchin F; Collins KK; Cannon BC; Alexander ME; Triedman JK; Walsh EP; Friedman RA
    J Am Coll Cardiol; 2008 Apr; 51(17):1685-91. PubMed ID: 18436121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate implantable cardioverter-defibrillator shock due to external alternating current leak: report of two cases.
    Chan NY; Wai-Ling Ho L
    Europace; 2005 Mar; 7(2):193-6. PubMed ID: 15763537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Termination of electrocution-induced ventricular fibrillation by an implantable cardioverter defibrillator.
    Ginwalla M; Battula S; Dunn J; Lewis WR
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):510-2. PubMed ID: 20015136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate shock delivery by implantable cardioverter defibrillator due to electrical interference with washing machine.
    Chongtham DS; Bahl A; Kumar RM; Talwar KK
    Int J Cardiol; 2007 May; 118(2):e44-5. PubMed ID: 17395291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
    Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator.
    Serizawa N; Yumino D; Kajimoto K; Tagawa Y; Takagi A; Shoda M; Kasanuki H; Hagiwara N
    Am J Cardiol; 2008 Oct; 102(8):1064-8. PubMed ID: 18929710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
    Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
    J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.
    Singh SN; Poole J; Anderson J; Hellkamp AS; Karasik P; Mark DB; Lee KL; Bardy GH;
    Am Heart J; 2006 Nov; 152(5):974.e7-11. PubMed ID: 17070171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An appropriate implantable cardioverter-defibrillator shock triggering unusual phenomenons.
    Arias MA; Puchol A; Colchero T; Pachón M; Castellanos E; Rodríguez-Padial L
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):1157-60. PubMed ID: 20487346
    [No Abstract]   [Full Text] [Related]  

  • 14. Inappropriate shock: a failure of SVT discriminators in a dual chamber ICD?
    Al-Ahmad A; Tsiperfal A; Hsia HH; Wang PJ
    Pacing Clin Electrophysiol; 2006 Dec; 29(12):1413-5. PubMed ID: 17201851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shocking truths about implantable cardioverter defibrillator monitoring zones.
    Mansour F; Thibault B; Dubuc M; Guerra PG; Macle L; Brugada R; Roy D; Talajic M; Khairy P
    Pacing Clin Electrophysiol; 2007 Sep; 30(9):1146-8. PubMed ID: 17725760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ventricular bigeminy as a cause of CRT inefficacy and inappropriate cardioverter-defibrillator intervention].
    Oreziak A; Przybylski A; Walczak F
    Kardiol Pol; 2009 Jul; 67(7):807-11. PubMed ID: 19650008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased N-terminal-pro-B-type natriuretic peptide levels in patients with appropriate implantable defibrillator therapies.
    Arnaldo FJ; Anatoliotakis N; Palacio C; Nabert DR; Hsu SS
    Heart Lung; 2009; 38(1):10-6. PubMed ID: 19150526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators in children.
    Blom NA
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S32-4. PubMed ID: 18226032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin Is Associated With Increased Shock Events and Electrical Storms in Patients With Implantable Cardioverter Defibrillators.
    Mina GS; Acharya M; Shepherd T; Gobrial G; Tekeste M; Watti H; Bhandari R; Saini A; Reddy P; Dominic P
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):142-148. PubMed ID: 28936878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.